Cite
HARVARD Citation
Frenck, R. et al. (2017). Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study. Vaccine. 35 (2), pp. 375-384. [Online].